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SUMMARY – Myxopapillary ependymomas (MPE) of the spinal cord are slow-growing benign 
tumors most frequently found in adults between 30 and 50 years of age. They arise from the ependyma 
of the filum terminale and are located in the area of the medullary conus and cauda. The recom-
mended treatment option is gross total resection, while patients undergoing subtotal resection usually 
require radiotherapy. Complete resection without capsular violation can be curative and is often ac-
complished by simple resection of the filum above and below the tumor mass. Nevertheless, dissemi-
nation and distant treatment failure may occur in approximately 30% of the cases. In this paper, we 
propose an original MPE classification, which is based upon our personal series report concerned with 
tumor location and its correlation with the extent of resection. We also provide literature review, dis-
cussing surgical technique, tumor recurrence rate and dissemination, and adjuvant treatment. In con-
clusion, our findings suggest that MPE management based on the proposed 5-type tumor classifica-
tion is favorable when total surgical resection is performed in carefully selected patients. Yet, further 
studies on a much broader model is obligatory to confirm this.
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Introduction
Spinal cord myxopapillary ependymoma (MPE) 
derives from the filum terminale1, representing the 
most common tumor of the medullary conus and ac-
counts for nearly 13% of all ependymomas2-4. Accord-
ing to the World Health Organization (WHO) clas-
sification5,6, MPE is a slow-growing grade I tumor, 
which is most often found in adults aged 30-50 years7. 
Although such a tumor is mainly situated in the lum-
bar spine just below the medullary conus, it may also 
spread to the thoracic spine, and sacrum8. Some of 
these tumors may become aggressive in spite of their 
benign histopathology, and they may metastasize 
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along the neural axis to distant cranial and spinal loca-
tions, or to local spots after surgery1,9. Therefore, gross 
total tumor resection, accompanied by intraoperative 
neuromonitoring, remains the best surgical manage-
ment option available9-11, while patients undergoing 
partial (subtotal) resection typically require adjuvant 
high-dose radiotherapy12,13. Complete tumor removal 
without iatrogenic capsular damage followed by sim-
ple resection of the filum above and below the tumor 
mass is always beneficial, but it may be difficult to ac-
Fig. 1. Preoperative sagittal post-contrast T1-weighted MRI of the spine showing  
a cystic contrast-enhancing tumor at medullary conus (L1-2) level (arrow)  
with syringomyelia at T10-12 level (a) and sagittal T2-weighted MRI visualizing 
the cyst and syringomyelia (arrow) better (b). Postoperative sagittal T2-weighted 
MRI revealing complete tumor resection with syringomyelia resolution (c).
Fig. 2. Preoperative sagittal T2-weighted spinal MRI revealing spinal cord cystic tumor with 
intratumoral hemorrhage at L1-L3 level (arrow), and subdural hematoma at S1 level (asterisk) (a). 
Axial T2-weighted MRI demonstrating the tumor cyst of the vertebral canal ventral part at L1 level 
(arrow) (b) and subdural hematoma of the dorsal part of the canal at S1 level (asterisk) (c). 
Postoperative sagittal T2-weighted MRI confirming complete tumor resection, hematoma 
evacuation, and spinal T12-L3 stabilization (d,e).
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complish. When rupture of the tumor capsule occurs 
during surgery, brain and whole spine adjuvant radio-
therapy is suggested to prevent local recurrence and 
cerebrospinal fluid (CSF) dissemination14. Preserva-
tion of sacrococcygeal nerve roots is vital to diminish 
the incidence of postoperative urinary dysfunction15. 
Nevertheless, neural axis dissemination, distant treat-
ment failure, and tumor relapse may occur in one-third 
of patients13.
Herein, we present a 7-case personal series report 
and propose an original anatomical and surgical MPE 
classification grounded on tumor location and its cor-
relation with the extent of resection16. We also provide 
a literature review, discussing surgical technique, tu-




A 45-year-old female was admitted to the hospital 
due to minor lower-limb motor weakness and urinary 
retention. A cystic contrast-enhancing tumor at L1-2 
level (arrow) with syringomyelia at T10-12 level was 
identified on preoperative sagittal post-contrast T1-
weighted spinal magnetic resonance imaging (MRI) 
(Fig. 1a). The cyst and syringomyelia (arrow) were well 
visualized on sagittal T2-weighted MRI (Fig. 1b). Ac-
cording to our classification, the tumor was deter-
mined to be type IV B MPE (involving the entire 
medullary conus with cystic compartment and signs of 
syringomyelia in the upper part of the cord). Postop-
erative sagittal T2-weighted MRI of the spine revealed 
complete tumor resection with syringomyelia resolu-
tion (Fig. 1c) resulting in full neurological recovery.
Case 2
A 43-year-old female presented with acute urinary 
retention and initial paraparesis. A spinal cord cystic 
tumor with intratumoral hemorrhage at L1-L3 level 
(arrow), and subdural hematoma at S1 level (asterisk) 
were visualized on sagittal T2-weighted MRI of the 
lumbar spine (Fig. 2a). Axial T2-weighted MRI dem-
onstrated tumor cyst of the vertebral canal ventral part 
at L1 level (arrow) (Fig. 2b), and subdural hematoma 
of the dorsal part of the canal at S1 level (asterisk) 
(Fig. 2c). The tumor was also classified as type IV B 
MPE (involving the entire medullary conus with cys-
tic compartment hemorrhage). Complete tumor resec-
tion, hematoma evacuation, and spinal T12-L3 stabili-
zation with transpedicular screws and rods were ac-
complished successfully, which was confirmed by post-
operative sagittal T2-weighted MRI (Fig. 2d,e) and 
resulted in full patient recovery.
Case 3
A 72-year-old female complained of low back and 
bilateral leg pain without any neurological deficit. Pre-
operative sagittal contrast-enhanced T1-weighted spi-
nal MRI demonstrated an intradural-extramedullary 
Fig. 3. Preoperative sagittal contrast-enhanced T1-weighted spinal MRI demonstrating an intradural-extramedullary 
tumor mass at L4 level (a) confined to filum terminale and adherent to the nerve roots (a). Preoperative T2-weighted 
sagittal (arrow) (b) and axial (arrow) MRI scans (c) visualizing the tumor confined to the filum terminale and 
adherent to the nerve roots. Postoperative sagittal T2-weighted MRI showing gross total tumor resection (d).
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tumor mass at L4 level (Fig. 3a). The tumor, which was 
confined to the filum terminale and adherent to the 
nerve roots, was also visible on preoperative T2-
weighted sagittal (arrow) (Fig. 3b) and axial (arrow) 
(Fig. 3c) MRI scans. The tumor was classified as type I 
B MPE (extramedullary conus with lumbar nerve root 
and filum involvement). Postoperative sagittal T2-
weighted MRI demonstrated gross total tumor resec-
tion (Fig. 3d). The patient reported no low back and 
leg pain following surgery.
Case 4
A 56-year-old female presented with low back 
pain, lower limb numbness, and voiding difficulties. 
Preoperative sagittal post-contrast T1-weighted MRI 
of the lumbar spine showed an enhancing solid tumor 
at L3 level affecting filum terminale and cauda equina 
(Fig. 4a), which was also shown on post-contrast axial 
T1-weighted (Fig. 4b) and sagittal T2-weighted (Fig. 
4c) MRI scans (arrows). The tumor was classified as 
type I B MPE (extramedullary conus with lumbar 
nerve root and filum involvement). Postoperative post-
contrast T1-weighted sagittal (Fig. 4d), axial (Fig. 4e), 
as well as sagittal T2-weighted MRI (Fig. 4f ) demon-
strated total tumor resection resulting in complete 
neurological recovery.
Case 5
A 47-year-old female presented with paraparesis, 
L2 level sensory loss, and bowel incontinence. Preop-
erative post-contrast sagittal T2-weighted (Fig. 5a) 
and T1-weighted (Fig. 5b) lumbar spine MRI demon-
strated a solid tumor mass at L3 level (arrows). The 
tumor was classified as type I B MPE (extramedullary 
conus with lumbar nerve root and filum involvement). 
Postoperative sagittal T2-weighted MRI confirmed 
complete tumor resection (Fig. 5c). The patient re-
mained neurologically intact following surgery.
Fig. 4. Preoperative sagittal post-contrast T1-weighted MRI of the lumbar spine showing  
an enhancing solid tumor at L3 level with engrossment of filum terminale and cauda equina 
(a), also shown on post-contrast axial T1-weighted (b) and sagittal T2-weighted MRI (c) 
(arrows). Postoperative post-contrast T1-weighted sagittal (d), axial (e) and sagittal  
T2-weighted MRI (f ) confirming total tumor resection.
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Case 6
A 35-year-old male presented with severe low back 
pain and urinary retention. Preoperative post-contrast 
sagittal T2-weigted (Fig. 6a) and T1-weighted (Fig. 
6b) lumbar MRI demonstrated a large cystic tumor at 
L2 level with hydromyelia and involvement of the 
medullary conus. The tumor was classified as type IV B 
MPE (involving the entire medullary conus with cys-
tic compartment and signs of hydromyelia in the up-
per part of the cord). Postoperative sagittal T2-weight-
ed MRI showed complete tumor resection with cyst 
drainage and hydromyelia resolution (Fig. 6c). Follow-
ing surgery, the patient reported no urinary retention 
or other neurological deficit.
Fig. 5. Preoperative post-contrast sagittal T2-weighted (a) and T1-weighted (b) 
lumbar spine MRI demonstrating a solid tumor mass at L3 level (arrows). 
Postoperative sagittal T2-weighted MRI confirming complete tumor resection (c).
Fig. 6. Preoperative post-contrast sagittal T2-weigted (a) and T1-weighted (b) lumbar MRI 
revealing a large cystic tumor at L2 level with hydromyelia and involvement of medullary conus. 
Postoperative sagittal T2-weighted MRI confirming complete tumor resection with cyst drainage  
and hydromyelia resolution (c).
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Case 7
A 33-year-old male presented with sudden urinary 
retention and no other symptoms or neurological im-
pairment. Preoperative post-contrast sagittal T2-
weighted MRI of the lumbar spine showed a large 
cystic tumor at L1-L2 level with involvement of the 
medullary conus and filum terminale (asterisk) (Fig. 
7a), while T1-weighted MRI revealed two additional 
lesions at L3 level, and S1 segment, which was the site 
of primary seeding (arrows) (Fig. 7b). Axial post-con-
trast T1-weighted MRI confirmed the separate tu-
mors at L1 (Fig. 7c) and L3 levels (Fig. 7d) (arrows). 
The tumor was classified as type IV B MPE (involving 
the entire medullary conus with cystic compartment). 
Postoperative sagittal T2-weighted (Fig. 7e) and post-
contrast T1-weighted MRI (Fig. 7f ) confirmed total 
resection of all the three tumors. Following surgery, 
urinary retention resolved entirely, and the patient re-
covered completely. Further MRI screenings excluded 
secondary seeding.
Discussion
We have proposed an original 5-type MPE classi-
fication based on tumor location and its correlation 
with the extent of resection16 (Table 1, Fig. 8). Accord-
ingly, extramedullary intradural MPEs incorporating 
filum terminale only represent type I A, where gross 
total resection is achievable easily. Type I B stands for 
extramedullary conus tumors involving lumbar nerve 
Table 1. Classification of spinal cord myxopapillary 
ependymoma
Type I A Filum terminale only
Type I B Extramedullary conus with lumbar nerve 
root and filum 
Type II Intramedullary conus and filum terminale 
Type III Upper lumbar cord enlargement
Type IV A Lower part of spinal cord and medullary 
conus with solid and cystic component 
Type IV B Entire medullary conus with cystic 
compartment and signs of hydromyelia/
syringomyelia in the cord upper part 
Type V A Outside the lumbar cord  
(cervical/thoracic spine)
Type V B Outside the vertebral canal  
(intracranial, sacrococcygeal)
Fig. 7. Preoperative post-contrast sagittal T2-weighted MRI of the lumbar spine demonstrating a large cystic tumor at 
L1-L2 level with involvement of medullary conus and filum terminale (asterisk) (a). Sagittal T1-weighted MRI 
revealing two additional lesions at L3 level, and S1 segment as the site of primary seeding (arrows) (b). Axial post-
contrast T1-weighted MRI depicting separate tumors at L1 (c) and L3 levels (d) (arrows). Postoperative sagittal T2-
weighted (e) and post-contrast T1-weighted MRI (f ) confirming total resection of all the three tumors.
roots together with filum terminale, which are surgi-
cally more challenging. Type II represents intramedul-
lary MPEs where conus and filum terminale are in-
volved that could be easily treated by gross total resec-
tion. Type III encompasses intramedullary MPEs in-
volving the lower spinal cord, medullary conus and 
filum, causing the upper lumbar cord enlargement. 
Type IV A stands for solid or cystic MPEs involving 
the lower spinal cord, while type IV B represents the 
entire medullary conus involvement with MPE having 
a cystic component, and signs of hydromyelia/syringo-
myelia upon the tumor site, where gross or subtotal 
resection are management options. Tumors located 
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Fig. 8. Schematic drawing of 5-type spinal cord MPE classification.
outside the lumbar cord, but still within the vertebral 
canal along the thoracic and/or cervical spine repre-
sent type V A MPE, whereas those located outside the 
vertebral canal epitomize type V B MPEs that may be 
situated at intracranial or sacrococcygeal regions.
Reviewing the literature, we found that the mean 
patient age at the time of tumor symptomatic occur-
rence was 36.44 years, and that medullary conus was 
involved in 28.4% of cases17, which was less consistent 
with our results where the mean patient age was 47.28 
years and the entire medullary conus was involved in 
four out of seven (57.1%) patients.
Younger age, preoperative functional capacity, less-
er initial neurological deficit, tumor location, size and 
the extent of resection, as well as adjuvant radiotherapy 
were identified as significant prognostic factors influ-
encing better outcome8,13,18,19. All the patients from our 
series had minor or lesser degree neurological deficit 
on admission, and total surgical tumor resection was 
possible in all of them.
Long-term outcome is also correlated to the extent 
of tumor resection, as well as to the integrity of the 
tumor capsule7,20, since larger tumors may perforate 
the capsule14, leading to CSF seeding and dissemina-
tion21. Hence, an association between capsular damage 
and tumor relapse was found22. Still, surgical morbidity 
is generally low and postoperative clinical improve-
ment is pretty good, while recurrence rate remains 
scarce when treatment recommendations and proto-
cols are strictly followed by an experienced neurosur-
geon and other medical staff7,23. The same happened 
with the patients from this series where no surgical 
morbidity and no tumor relapse or dissemination was 
observed. Accordingly, Klekamp et al. report that gross 
total tumor resection was achieved in 77.7% of their 
patients7, while several studies suggest that it must be 
combined with high-dose radiotherapy in order to im-
prove the outcome24-26, and to avoid recurrence, as well 
as primary and secondary seeding, which remains un-
der-recognized in adults1,27. Although tumor benign 
histologic features are commonly preserved in case of 
dissemination28, rostral neuro-axial spread mostly af-
fects the thoracic and cervical spine29,30. Then, addi-
tional resection or irradiation would be endorsed if 
metastases become symptomatic30. There are single 
case reports describing the benefits of second- and 
third-line chemotherapy concomitant with radiother-
apy after multiple surgeries of recurrent MPE with 
disseminated metastases31,32. However, this was not the 
case in patients from our series, since all of them re-
covered well after total tumor resection. Therefore, the 
need for repeat surgery or adjuvant therapy was not 
established and no tumor relapse or dissemination was 
recorded. Nonetheless, one should still remember the 
possibility of tumor relapse, primary seeding, and drop 
metastases; one should also consider the entire cranio-
spinal neuroimaging as part of both the preoperative 
work-up and postoperative follow-up1. Therefore, 
long-term or lifelong MRI surveillance should be ad-
vised1,16, which is also part of our patient protocol.
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In conclusion, having in mind the small number of 
patients in this personal case series, as well as its retro-
spective design, our findings suggest that MPE man-
agement based on the proposed 5-type tumor classifi-
cation is favorable when total surgical resection is per-
formed in carefully selected patients, which is well-
supported by the literature data. Yet, additional studies 
on a much broader model are obligatory to confirm 
these results.
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Sažetak
MIKSOPAPILARNI EPENDIMOM KRALJEŽNIČNE MOŽDINE U ODRASLIH:  
PRIKAZ OSOBNE SERIJE I PREGLED LITERATURE
I. Omerhodžić, M. Pojskić, K Rotim, B. Splavski, L Rasulić i K. Arnautovic
Miksopapilarni ependimomi (MPE) kralježnične moždine sporo su rastući, dobroćudni tumori najčešće zastupljeni u 
odraslih u dobi između 30 i 50 godina života. Nastaju iz ependima filuma terminale, a pretežito su smješteni u području 
medularnoga konusa i kaude. Kirurško uklanjanje tumora u cijelosti preporučena je metoda liječenja, dok u bolesnika u kojih 
to nije moguće učiniti u obzir dolazi subtotalna resekcija nakon koje je potrebno zračenje. Potpuno uklanjanje tumora uz 
očuvanje cjelovitosti tumorske kapsule postiže se jednostavnom resekcijom filuma terminale iznad i ispod tumorske mase, što 
može dovesti do izlječenja. Unatoč tomu, tumorska diseminacija uzduž neuralne osi može se javiti u oko 30% slučajeva. U 
ovom radu predlažemo originalnu klasifikaciju MPE koja prosuđuje smještaj tumora i obujam tumorske resekcije, a temelje-
na je na osobnoj seriji operiranih bolesnika. Također raspravljamo o kirurškoj tehnici, o mogućnostima recidiva i širenja 
ovakvih tumora, kao i o oblicima pomoćnog liječenja, koristeći se pregledom literature. Zaključujemo kako naši rezultati 
zagovaraju kirurško liječenje temeljeno na predloženoj originalnoj tumorskoj klasifikaciji, koje može biti uspješno u pažljivo 
odabranih bolesnika u kojih je tumor uklonjen u cijelosti. Naknadna istraživanja na znatno većem uzorku potrebna su za 
potvrdu naših rezultata.
Ključne riječi: Miksopapilarni ependimom; Potpuna resekcija tumora; Kirurška tehnika; Klasifikacija tumora
